V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310003064 | 310008990 | null | 55.5 | Palliative (P) | 2016-04-20 | 2016-04-22 | PEMBROLIZUMAB | 02 | N | 310017149 | PEMBROLIZUMAB |
| 310003065 | 310001306 | 1.66 | 11.64 | Palliative (P) | 2017-05-24 | 2017-06-08 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310017150 | CISPLATIN + GEMCITABINE |
| 310003066 | 310001306 | null | 3.5 | Palliative (P) | 2014-10-07 | 2014-10-10 | CISPLATIN + GEMCITABINE | N | N | 310017150 | CISPLATIN + GEMCITABINE |
| 310003067 | 310001306 | null | 71.8 | Palliative (P) | 2015-10-14 | 2015-10-20 | Ipilimumab | 02 | N | 310017150 | IPILIMUMAB |
| 310003068 | 310001306 | 1.77 | 62.5 | Palliative (P) | 2015-09-19 | 2015-09-19 | Trial Unspecified | Y | Y | 310017150 | TRIAL |
| 310003069 | 310001307 | 1.82 | 107 | Palliative (P) | 2018-08-27 | 2018-09-06 | Ipilimumab | 02 | N | 310017157 | IPILIMUMAB |
| 310003070 | 310001308 | 1.72 | null | Curative (C) | 2014-11-10 | 2014-11-14 | CHOP R - 14 days | 2 | N | 310017158 | CHOP R |
| 310003071 | 310006523 | 1.81 | 72.65 | Palliative (P) | 2013-03-10 | 2013-03-10 | Cisplatin + Gemcitabine (D 1 & 8) | null | N | 310017160 | CISPLATIN + GEMCITABINE |
| 310003072 | 310006523 | 0 | 10.3 | Curative (C) | 2015-07-17 | 2015-07-17 | Retinoblastoma JOE | 2 | N | 310017160 | CEV |
| 310003073 | 310006523 | 1.58 | 54 | Palliative (P) | 2013-02-13 | 2013-02-13 | CISPLATIN + GEMCITABINE | 02 | N | 310017160 | CISPLATIN + GEMCITABINE |
| 310003074 | 310006523 | 0 | 79 | Adjuvant (A) | 2015-04-25 | 2015-04-25 | Retinoblastoma JOE | N | N | 310017160 | CEV |
| 310003075 | 310006523 | 1.78 | 112.8 | Palliative (P) | 2017-10-16 | 2017-11-07 | Ipilimumab | N | null | 310017160 | IPILIMUMAB |
| 310003076 | 310006523 | 1.74 | null | Palliative (P) | 2017-05-17 | 2017-05-21 | PEMBROLIZUMAB | 02 | N | 310017160 | PEMBROLIZUMAB |
| 310003077 | 310006523 | 1.61 | 77.4 | Palliative (P) | 2016-08-10 | 2016-08-19 | CISPLATIN + GEMCITABINE | 02 | N | 310017160 | CISPLATIN + GEMCITABINE |
| 310003078 | 310001309 | 1.7 | 46.7 | Palliative (P) | 2014-09-22 | 2014-10-10 | PEMBROLIZUMAB | N | N | 310017198 | PEMBROLIZUMAB |
| 310003079 | 310001309 | null | 64.6 | Radical (R) | 2017-07-08 | 2017-07-08 | CHOP R - 21 days | 2 | Y | 310017198 | CHOP R |
| 310003080 | 310001309 | 1.77 | 14.6 | Curative (C) | 2016-06-19 | 2016-06-29 | Cisplatin | N | N | 310017198 | CISPLATIN |
| 310003081 | 310001309 | 1.79 | 85 | Palliative (P) | 2014-05-16 | 2014-05-26 | DOXORUBICIN | N | N | 310017198 | DOXORUBICIN |
| 310003082 | 310001309 | 1.85 | 93.1 | Palliative (P) | 2017-08-14 | 2017-08-15 | PEMBROLIZUMAB | 02 | N | 310017198 | PEMBROLIZUMAB |
| 310003083 | 310001310 | 1.72 | 83 | Palliative (P) | 2016-11-30 | 2016-12-07 | Carboplatin + Etoposide iv&po | N | N | 310017213 | CARBOPLATIN + ETOPOSIDE |
| 310003085 | 310001312 | 0 | 11.6 | Curative (C) | 2013-11-07 | 2013-11-07 | Retinoblastoma JOE | 2 | N | 310017215 | CEV |
| 310003086 | 310001312 | 1.73 | 84 | Adjuvant (A) | 2017-03-30 | 2017-04-10 | Cisplatin 7 day | 02 | N | 310017215 | CISPLATIN |
| 310003087 | 310001313 | null | 90 | null | 2016-11-26 | 2016-12-17 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 310017220 | CISPLATIN + GEMCITABINE |
| 310003088 | 310001314 | 1.58 | 72.1 | Palliative (P) | 2015-08-26 | 2015-08-26 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 310017222 | CISPLATIN + GEMCITABINE |
| 310003089 | 310001314 | null | null | null | 2017-04-30 | 2017-05-01 | Ipilimumab | 02 | null | 310017222 | IPILIMUMAB |
| 310003090 | 310008994 | 1.7 | 12.5 | Palliative (P) | 2018-04-13 | 2018-04-14 | PEMBROLIZUMAB | 2 | N | 310017225 | PEMBROLIZUMAB |
| 310003091 | 310001315 | 1.61 | 74.4 | null | 2013-09-05 | 2013-09-17 | Doxorubicin 75mg/m2 | N | N | 310017228 | DOXORUBICIN |
| 310003092 | 310001316 | 1.93 | 85.6 | Palliative (P) | 2014-06-29 | 2014-07-01 | PEMBROLIZUMAB | 02 | N | 310017231 | PEMBROLIZUMAB |
| 310003093 | 310001316 | 1.79 | 97.6 | Curative (C) | 2014-09-08 | 2014-09-10 | Cisplatin 7 day | 02 | Y | 310017231 | CISPLATIN |
| 310003094 | 310001316 | 1.78 | 72.1 | Palliative (P) | 2016-12-11 | 2017-02-12 | Ipilimumab | N | N | 310017231 | IPILIMUMAB |
| 310003095 | 310001317 | 1.81 | null | Palliative (P) | 2017-04-18 | 2017-04-18 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | 310017236 | CISPLATIN + GEMCITABINE |
| 310003096 | 310006528 | null | 74 | Curative (C) | 2015-05-21 | 2015-05-24 | Retinoblastoma JOE | N | N | 310017238 | CEV |
| 310003097 | 310001318 | 1.6 | 59.7 | Palliative (P) | 2014-06-08 | 2014-06-20 | Carboplatin + Etoposide iv&po | N | N | 310017239 | CARBOPLATIN + ETOPOSIDE |
| 310003098 | 310001318 | null | 86 | Curative (C) | 2013-09-18 | 2013-09-19 | Retinoblastoma JOE | N | N | 310017239 | CEV |
| 310003099 | 310001319 | 1.65 | 84.8 | Curative (C) | 2013-05-15 | 2013-05-16 | Cisplatin 7 day | N | Y | 310017242 | CISPLATIN |
| 310003100 | 310001320 | 1.6 | null | Curative (C) | 2014-10-08 | 2014-10-21 | CHOP R - 21 days | N | N | 310017246 | CHOP R |
| 310003101 | 310001321 | 1.73 | 91.6 | Palliative (P) | 2017-01-13 | 2017-01-14 | PEMBROLIZUMAB | 02 | N | 310017250 | PEMBROLIZUMAB |
| 310003102 | 310001321 | null | 86.1 | Palliative (P) | 2016-07-15 | 2016-07-31 | Ipilimumab | N | N | 310017250 | IPILIMUMAB |
| 310003103 | 310001321 | 1.7 | 89.6 | Palliative (P) | null | 2013-10-12 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310017250 | CISPLATIN + GEMCITABINE |
| 310003104 | 310001322 | 1.57 | 69.1 | Palliative (P) | 2014-08-12 | 2014-08-15 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310017258 | CISPLATIN + GEMCITABINE |
| 310003105 | 310001323 | null | 50.5 | Curative (C) | 2015-02-28 | 2015-03-16 | Retinoblastoma JOE | N | N | 310017264 | CEV |
| 310003106 | 310001324 | 1.66 | 58.2 | Not known (9) | 2017-10-27 | 2017-11-02 | PEMBROLIZUMAB | N | N | 310017265 | PEMBROLIZUMAB |
| 310003107 | 310001324 | 1.57 | 58.3 | Palliative (P) | 2015-03-28 | 2015-03-28 | Carboplatin + Etoposide IV 3 day | N | null | 310017265 | CARBOPLATIN + ETOPOSIDE |
| 310003108 | 310001325 | 1.73 | 63 | Palliative (P) | 2014-07-29 | 2014-08-06 | DOXORUBICIN | N | N | 310017269 | DOXORUBICIN |
| 310003109 | 310001326 | 1.89 | 64.9 | Palliative (P) | 2017-03-31 | 2017-04-05 | PEMBROLIZUMAB | 2 | N | 310017271 | PEMBROLIZUMAB |
| 310003110 | 310001327 | 1.82 | 11.3 | Curative (C) | 2013-12-15 | 2013-12-15 | CHOP R - 21 days | 2 | N | 310017273 | CHOP R |
| 310003111 | 310006532 | 1.78 | 99.9 | Palliative (P) | 2014-05-31 | 2014-06-07 | CISPLATIN + GEMCITABINE | 02 | N | 310017274 | CISPLATIN + GEMCITABINE |
| 310003112 | 310001328 | 1.87 | 97.2 | Palliative (P) | null | 2017-12-09 | DOXORUBICIN | N | N | 310017275 | DOXORUBICIN |
| 310003113 | 310001328 | 1.72 | 46 | null | 2014-04-18 | 2014-04-18 | Ipilimumab | 2 | N | 310017275 | IPILIMUMAB |
| 310003114 | 310001329 | 1.64 | 47 | Palliative (P) | 2013-08-02 | 2013-08-03 | Carboplatin + Etoposide iv&po | N | N | 310017277 | CARBOPLATIN + ETOPOSIDE |